Compare Source Natural with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 89 Cr (Micro Cap)
29.00
32
0.00%
0.01
13.33%
3.89
Total Returns (Price + Dividend) 
Source Natural for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Source Natural Foods & Herbal Supplements Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns
Source Natural Foods & Herbal Supplements Ltd has been downgraded from a Sell to a Strong Sell rating as of 5 February 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the stock’s overall outlook has worsened due to bearish technical trends, subpar valuation metrics, and disappointing long-term returns compared to benchmark indices.
Read full news article
Source Natural Foods & Herbal Supplements Ltd is Rated Sell
Source Natural Foods & Herbal Supplements Ltd is rated Sell by MarketsMOJO. This rating was last updated on 13 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 03 February 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Source Natural Foods & Herbal Supplements Ltd is Rated Sell
Source Natural Foods & Herbal Supplements Ltd is rated Sell by MarketsMOJO. This rating was last updated on 13 January 2026, reflecting a shift from a previous 'Strong Sell' stance. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 January 2026, providing investors with an up-to-date view of the stock's position in the market.
Read full news article Announcements 
Announcement Under Regulation 30 (LODR) 2015 - Outcome Of Board Meeting For Proposed Incorporation Of A Wholly-Owned Subsidiary.
12-Jan-2026 | Source : BSEOutcome of Board Meeting - Proposed Incorporation of a Wholly-owned Subsidiary
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025
Closure of Trading Window
31-Dec-2025 | Source : BSEClosure of Trading window for the quarter and nine months ended December 31 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sriveda Sattva Private Limited (74.37%)
Guttikonda Vara Lakshmi (2.96%)
18.68%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 40.08% vs -24.70% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 11.11% vs 0.00% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 57.79% vs 47.63% in Sep 2024
Growth in half year ended Sep 2025 is 5.56% vs 173.91% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 40.99% vs 58.19% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 60.56% vs 40.59% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 64.54% vs 38.09% in Mar 2024
YoY Growth in year ended Mar 2025 is 66.67% vs -17.92% in Mar 2024






